- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Pregnancy
Volume 2013 (2013), Article ID 826045, 6 pages
Eclampsia Characteristics and Outcomes: A Comparison of Two Eras
1Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, 853 Jefferson Avenue, Room E102, Memphis, TN 38163, USA
2Eastern Virginia Medical School, 825 Faifax Avenue, Norfolk, VA 23507, USA
Received 19 January 2013; Accepted 6 March 2013
Academic Editor: Antonio Farina
Copyright © 2013 Mauro H. Schenone et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- ACOG Committee on Practice Bulletins—Obstetrics, “ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002,” Obstetrics and Gynecology, vol. 99, no. 1, pp. 159–167, 2002.
- F. Mattar and B. M. Sibai, “Eclampsia. VIII. Risk factors for maternal morbidity,” The American Journal of Obstetrics and Gynecology, vol. 182, no. 2, pp. 307–312, 2000.
- A. F. Saftlas, D. R. Olson, A. L. Franks, H. K. Atrash, and R. Pokras, “Epidemiology of preeclampsia and eclampsia in the United States, 1979–1986,” The American Journal of Obstetrics and Gynecology, vol. 163, no. 2, pp. 460–465, 1990.
- C. Jodicke, D. Maulik, P. Singh, E. Heitmann, and D. Maulik, “Role of ultrasound in pre-eclampsia,” Minerva Ginecologica, vol. 64, no. 4, pp. 293–308, 2012.
- I. Cetin, B. Huppertz, G. Burton et al., “Pregenesys pre-eclampsia markers consensus meeting: what do we require from markers, risk assessment and model systems to tailor preventive strategies?” Placenta, vol. 32, supplement 1, pp. S4–S16, 2011.
- H. J. Odendaal, R. C. Pattinson, R. Bam, D. Grove, and T. J. V. W. Kotze, “Aggressive or expectant management for patients with severe preeclampsia between 28–34 weeks' gestation: a randomized controlled trial,” Obstetrics and Gynecology, vol. 76, no. 6, pp. 1070–1075, 1990.
- B. M. Sibai, B. M. Mercer, E. Schiff, and S. A. Friedman, “Aggressive Versus expectant management of severe preeclampsia at 28 to 32 weeks' gestatian: a randomized controlled trial,” The American Journal of Obstetrics and Gynecology, vol. 171, no. 3, pp. 818–822, 1994.
- B. M. Sibai and J. R. Barton, “Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications,” The American Journal of Obstetrics and Gynecology, vol. 196, no. 6, pp. 514.e1–514.e9, 2007.
- A. M. Gulmezoglu and L. Duley, “Use of anticonvulsants in eclampsia and pre-eclampsia: survey of obstetricians in the United Kingdom and Republic of Ireland,” The British Medical Journal, vol. 316, no. 7136, pp. 975–976, 1998.
- D. Altman, G. Carroli, L. Duley et al., “Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial,” The Lancet, vol. 359, no. 9321, pp. 1877–1890, 2002.
- S. Liu, K. S. Joseph, R. M. Liston et al., “Incidence, risk factors, and associated complications of eclampsia,” Obstetrics and Gynecology, vol. 118, no. 5, pp. 987–994, 2011.
- J. J. Zwart, A. Richters, F. Öry, J. I. P. de Vries, K. W. M. Bloemenkamp, and J. van Roosmalen, “Eclampsia in the Netherlands,” Obstetrics and Gynecology, vol. 112, no. 4, pp. 820–827, 2008.
- M. Knight, “Eclampsia in the United Kingdom 2005,” BJOG: An International Journal of Obstetrics and Gynaecology, vol. 114, no. 9, pp. 1072–1078, 2007.
- E. D. Adinma, “Maternal and perinatal outcome of eclampsia in tertiary health institution in southeast nigeria,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 26, no. 2, pp. 211–214, 2013.
- “Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial,” The Lancet, vol. 345, no. 8963, pp. 1455–1463, 1995.
- M. P. Appleton, T. J. Kuehl, M. A. Raebel, H. R. Adams, A. B. Knight, and W. R. Gold, “Magnesium sulfate versus phenytoin for seizure prophylaxis in pregnancy-induced hypertension,” The American Journal of Obstetrics and Gynecology, vol. 165, no. 4, part 1, pp. 907–913, 1991.
- M. W. Atkinson, D. Guinn, J. Owen, and J. C. Hauth, “Does magnesium sulfate affect the length of labor induction in women with pregnancy-associated hypertension?” The American Journal of Obstetrics and Gynecology, vol. 173, no. 4, pp. 1219–1222, 1995.
- M. A. Belfort, J. Anthony, G. R. Saade, and J. C. Allen Jr., “A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia,” The New England Journal of Medicine, vol. 348, no. 4, pp. 304–311, 2003.
- A. K. Bhalla, G. I. Dhall, and K. Dhall, “A safer and more effective treatment regimen for eclampsia,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 34, no. 2, pp. 144–148, 1994.
- E. J. Coetzee, J. Dommisse, and J. Anthony, “A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia,” The British Journal of Obstetrics and Gynaecology, vol. 105, no. 3, pp. 300–303, 1998.
- C. Crowther, “Magnesium sulphate versus diazepam in the management of eclampsia: a randomized controlled trial,” The British Journal of Obstetrics and Gynaecology, vol. 97, no. 2, pp. 110–117, 1990.
- J. Dommisse, “Phenytoin and magnesium sulfate in eclampsia (I),” The American Journal of Obstetrics and Gynecology, vol. 163, no. 3, pp. 1089–1091, 1990.
- S. A. Friedman, K. H. Lim, C. A. Baker, and J. T. Repke, “Phenytoin versus magnesium sulfate in preeclampsia: a pilot study,” The American Journal of Perinatology, vol. 10, no. 3, pp. 233–238, 1993.
- D. R. Hall, H. J. Odendaal, and M. Smith, “Is the prophylactic administration of magnesium sulphate in women with pre-eclampsia indicated prior to labour?” The British Journal of Obstetrics and Gynaecology, vol. 107, no. 7, pp. 903–908, 2000.
- M. J. Lucas, K. J. Leveno, and F. G. Cunningham, “A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia,” The New England Journal of Medicine, vol. 333, no. 4, pp. 201–205, 1995.